Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3).
暂无分享,去创建一个
A. Fattorossi | G. Scambia | A. Battaglia | Alexia Buzzonetti | M. Fossati | Valentina Catzola | G. Monego